Aripiprazole-induced Tardive Dyskinesia in 13 Years Old Girl Successfully Treated with Biperiden: A Case Report
Clinical Psychopharmacology and Neuroscience
;
: 285-287, 2017.
Article
Dans Anglais
| WPRIM
| ID: wpr-152976
ABSTRACT
In the last years second-generation antipsychotics are increasingly prescribed in the pediatric population for the treatment of several psychiatric disorders. Among the long term adverse effects, extrapyramidal symptoms (EPS) are less reported compared to first-generation antipsychotics. Tardive dyskinesia (TD) is a iatrogenic rare syndrome characterized by persistent slow writhing and sudden involuntary movements mainly involving the oral-buccal-lingual area with masticatory movements. We report a young girl with mood disorders accompanied by mild intellectual disability and behavioral problems who had TD after treatment with Aripiprazole, which responded to Biperiden therapy.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Pédiatrie
/
Neuroleptiques
/
Bipéridène
/
Troubles de l'humeur
/
Dyskinésies
/
Effets secondaires indésirables des médicaments
/
Effets indésirables à long terme
/
Aripiprazole
/
Comportement déviant
/
Déficience intellectuelle
Limites du sujet:
Femelle
/
Humains
langue:
Anglais
Texte intégral:
Clinical Psychopharmacology and Neuroscience
Année:
2017
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS